Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Platform
Pipeline
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
SEC Filings
Governance
Connect
SEC Filings
To view the webinar replay of “PRECISE-AD Phase 1b Blinded Interim Data Analysis"
Click Here
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: PMN
Analyst Coverage
SEDAR
SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-12B
10-12B/A
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B5
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
SUPPL
UPLOAD
Year:
View All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Date
Form
Description
PDF
Pages
10/30/23
4
Statement of changes in beneficial ownership of securities
1
10/30/23
4
Statement of changes in beneficial ownership of securities
1
10/30/23
4
Statement of changes in beneficial ownership of securities
1
10/30/23
4
Statement of changes in beneficial ownership of securities
1
10/30/23
4
Statement of changes in beneficial ownership of securities
1
09/29/23
EFFECT
Notice of Effectiveness
1
09/29/23
EFFECT
Notice of Effectiveness
1
09/27/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
09/27/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
09/27/23
S-3/A
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-4.3
EX-5.1
40
arrow_back
1…
16
17
18
19
20
21
22
23
24
25
…37
arrow_forward
Email Alerts
Contacts